Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloma, Plasma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT05270928
What this trial is testing

Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y001#

Who this might be right for
Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University 6
Testing effectiveness (Phase 2)Looking for participantsNCT05572229
What this trial is testing

Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Lille 74
Large-scale testing (Phase 3)Study completedNCT00452569
What this trial is testing

Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 499
Not applicableStudy completedNCT05123001
What this trial is testing

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

Who this might be right for
Hodgkin LymphomaNon Hodgkin LymphomaLeukemia+1 more
Stanford University 11
Testing effectiveness (Phase 2)WithdrawnNCT03608501
What this trial is testing

Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

Who this might be right for
Multiple Myeloma
Takeda
Testing effectiveness (Phase 2)Ended earlyNCT03910439
What this trial is testing

Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma

Who this might be right for
Myeloma, MultipleMyeloma-Multiple
National Cancer Institute (NCI) 4
Large-scale testing (Phase 3)Study completedNCT00083876
What this trial is testing

D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 500
Testing effectiveness (Phase 2)Looking for participantsNCT06911710
What this trial is testing

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

Who this might be right for
Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)AML (Acute Myelogenous Leukemia)Myeloma Multiple+3 more
Tianjin Medical University General Hospital 90
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Testing effectiveness (Phase 2)Study completedNCT04478123
What this trial is testing

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Who this might be right for
Multiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 62
Very early researchNot Yet RecruitingNCT04670055
What this trial is testing

Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Zhejiang University 50
Testing effectiveness (Phase 2)Study completedNCT00216697
What this trial is testing

An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 13
Testing effectiveness (Phase 2)Ended earlyNCT01997840
What this trial is testing

ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 103
Not applicableNo Longer AvailableNCT04453397
What this trial is testing

Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
TeneoOne Inc.
Very early researchLooking for participantsNCT07493135
What this trial is testing

IMV102 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Suzhou Immunofoco Biotechnology Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT01745640
What this trial is testing

Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)

Who this might be right for
Multiple Myeloma
University Hospital, Lille 63
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Early research (Phase 1)Active Not RecruitingNCT05050097
What this trial is testing

Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 166
Next Page